NTRK1 and cancer: The Reactome pathway enrichment analysis showed that the interleukin-related pathway, receptor tyrosine kinase (RTK) signaling, VEGFR2-mediated proliferation regulatory signals, and interferon alpha/beta signaling pathway were upregulated in cancer cells located in the S components.